Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score N/A
- Piotroski Score N/A
- Grade Overweight
- Symbol (MRX)
- Company Marex Group plc Ordinary Shares
- Price $23.60
- Changes Percentage (0.08%)
- Change $0.02
- Day Low $22.76
- Day High $23.97
- Year High $26.03
- Last Earnings 07/23/2024
- Ex-Dividend for 5/16 Dividend 08/30/2024
- Dividend Payable 09/16/2024
- Today N/A
- Next Earnings (Estimated) 08/14/2024
- Fiscal Year End N/A
- Average Stock Price Target $27.00
- High Stock Price Target $33.00
- Low Stock Price Target $24.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio N/A
- Forward P/E Ratio N/A
- P/E Growth N/A
- Net Income $128.00 M
Income Statement
Quarterly
Annual
Latest News of MRX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Here's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation
Investors are often attracted to unprofitable companies like Amazon, which turned profitable over time. Analyzing Chimerix's cash burn and runway, it's crucial to assess its financial health for poten...
By Yahoo! Finance | 1 week ago -
Jim Cramer Says Cardinal Health Inc. (CAH) Built A More Stable Foundation And Delivered Impressive Results After Losing The OptumRx Business
Jim Cramer's bullish stock picks include Cardinal Health Inc., showing impressive growth despite challenges. Cramer emphasizes investing in exceptional companies for long-term success, highlighting th...
By Yahoo! Finance | 1 month ago -
Insider Sale at Amneal Pharmaceuticals Inc (AMRX) by Executive Vice President Andrew Boyer
Andrew Boyer, Executive VP of Amneal Pharmaceuticals Inc, sold 62,711 shares, now owning 256,670 shares. The company has seen insider selling recently, with no buys. With a market cap of $2....
By Yahoo! Finance | 1 month ago